Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2019 Oct-Dec;33(4):315–320. doi: 10.1097/WAD.0000000000000334

Table 1-.

Characteristics of participants across TDP-43 stages (n=293)

TDP-43 Stages
Stage 0, n=150 Stage 1, n=58 Stage 2, n=45 Stage 3, n=40
Demographics
Age-at-death, y, mean (SD) 89.5 (6.50) 91.3 (6.17) 93.0 (4.75 101.6 (4.11)
Female, n % 103 (68.7%) 43 (74.1%) 31 (68.9%) 37 (92.5%)
Education, y, mean (SD) 15.4 (3.37) 18.8 (3.14) 14.8 (2.92) 15.6 (2.61)
Clinical (proximate-to-death)
Literacy score, mean (SD) 60.5 (17.93) 53.1 (17.70) 52.36 (15.40) 43.1 (13.35)
MMSE score, mean (SD) 24.0 (6.96) 22.2 (8.22) 22.05 (6.95) 16.6 (9.51)
Global cognition, mean (SD) −0.5 (1.07) −0.7 (1.05) −0.9 (1.04) −1.5 (1.01)
Pathologic
AD pathology score, mean (SD) 0.6 (1.07) 0.8 (0.62) 0.7 (0.49) 1.09 (0.59)
NIA-Reagan, n (%) 90 (60%) 40 (69.0%) 32 (71.1%) 36 (90.0%)

Abbreviations: y – Years; SD – Standard deviation, MMSE – Mini-Mental-State-Examination; AD – Alzheimer’s disease; TDP-43 – Transactive response DNA-Binding Protein 43